Nanoparticles of biodegradable polymers for clinical administration of paclitaxel

SS Feng, L Mu, KY Win, G Huang - Current Medicinal Chemistry, 2004 - ingentaconnect.com
Paclitaxel is one of the best antineoplastic drugs found from nature in the past decades,
which has been found effective against a wide spectrum of cancers including ovarian …

PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio

L Mu, SS Feng - Pharmaceutical research, 2003 - Springer
Purpose. We successfully manufactured nanoparticles of biodegradable polymers for
controlled release of paclitaxel. TPGS (d-α-tocopheryl polyethylene glycol 1000 succinate) …

[HTML][HTML] Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: A co-surfactant study

N Sharma, P Madan, S Lin - Asian journal of pharmaceutical sciences, 2016 - Elsevier
The purpose of this study was to evaluate the effect of process (homogenization speed and
evaporation time) and formulation (aqueous/organic phase ratio, surfactant concentration …

The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly (lactide)–tocopheryl polyethylene glycol succinate …

Z Zhang, SS Feng - Biomaterials, 2006 - Elsevier
Paclitaxel is one of the most effective antineoplastic drugs. Its current clinical administration
is formulated in Cremophor EL, which causes serious side effects. Nanoparticle (NP) …

Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid

CG Keum, YW Noh, JS Baek, JH Lim… - International journal …, 2011 - Taylor & Francis
Background Nanoparticles fabricated from the biodegradable and biocompatible polymer,
polylactic-co-glycolic acid (PLGA), are the most intensively investigated polymers for drug …

Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies

L Zhao, SS Feng - Journal of pharmaceutical sciences, 2010 - Elsevier
This work evaluates the effects of paclitaxel loaded polymeric nanoparticles (NPs)
composed of poly (D, L-lactic-co-glycolic acid)(PLGA) with vitamin E TPGS as emulsifier for …

Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers

S Feng, G Huang - Journal of Controlled Release, 2001 - Elsevier
Paclitaxel (Taxol®) is an antineoplastic drug effective for various cancers especially ovarian
and breast cancer. Due to its high hydrophobicity, however, an adjuvant such as Cremophor …

Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity

C Fonseca, S Simoes, R Gaspar - Journal of controlled release, 2002 - Elsevier
The main objective of this study was to develop a polymeric drug delivery system for
paclitaxel, intended to be intravenously administered, capable of improving the therapeutic …

A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS

L Mu, SS Feng - Journal of controlled release, 2003 - Elsevier
Paclitaxel (Taxol®) is one of the best antineoplastic drugs found from nature in the past
decades. Like many other anticancer drugs, there are difficulties in its clinical administration …

Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel

C Wang, YJ Wang, YJ Wang, M Fan, F Luo… - International journal of …, 2011 - Elsevier
Polymeric nanoparticles (NPs) have great potential application in achieving targeted
delivery of anticancer drugs. Paclitaxel (PTX) loaded NPs were developed using …